Featured Content

5-Year Survival in Breast Cancer

Researchers question the meaning of 5-year survival and stress the importance of context in discussing survivorship related to breast cancer.

Breast Cancer in Transgendered Persons

A conversation with George R. Brown, MD, DFAPA, to discuss the recent reporting of 10 additional cases of breast cancer among transgendered persons.

Inhibiting the PI3K Pathway in Breast Cancer

The fact that a tumor's response to a PI3K inhibitor cannot be predicted has led to myriad clinical trials of agents targeting this signal transduction ...

Standard of Care for Early-Stage Breast Cancer

Trastuzumab has been approved for nearly a decade, but it is still unclear which women with early-stage disease might benefit most from treatment.

Breast Cancer Risk Prediction Models

Studies explore the features to assess in a risk model to predict probability of breast cancer in women with benign breast biopsy or African American ...

Breast Cancer Resources

More Breast Cancer Information

How to Communicate Metastatic Breast Cancer Pain

This fact sheet educates patients on how to properly describe the details of their metastatic breast cancer pain to their oncologist.

Molecular Profiling: Personalizing Breast Cancer Treatment

This patient information fact sheet reviews how doctors use molecular profiling to offer patients more targeted therapy options.

BRCA1 and BRCA2: Cancer Risk and Genetic Testing

This fact sheet provides information about the BRCA1 and BRCA2 genes and related genetic testing.

Can Antiperspirants/Deodorants Cause Breast Cancer?

This fact sheet discusses evidence behind if antiperspirants and deodorants may be linked to breast cancer.

Hormone Therapy in Breast Cancer

This fact sheet teaches patients how hormone therapy can help stop the growth of hormone-sensitive breast cancer tumors.

IBRANCE (palbociclib) for Metastatic Breast Cancer

IBRANCE (palbociclib) for Metastatic Breast Cancer

This slideshow reviews drug information for IBRANCE (palbociclib), indicated for metastatic breast cancer.
Table of Contents
Slide 3: Indication, Dosage, and Administration
Slide ...

TYKERB (lapatinib) for Metastatic Breast Cancer

TYKERB (lapatinib) for Metastatic Breast Cancer

This slideshow reviews drug information for TYKERB (lapatinib), indicated for metastatic breast cancer.
Table of Contents
Slide 3: Indication, Dosage, and Administration
Slide ...

IXEMPRA® (ixabepilone) for Metastatic or Locally Advanced Breast Cancer

IXEMPRA® (ixabepilone) for Metastatic or Locally Advanced Breast Cancer

This slideshow reviews drug information for IXEMPRA® (ixabepilone), indicated for metastatic or locally advanced breast cancer.
Table of Contents
Slide 3: Indication, ...

HALAVEN (eribulin mesylate) for Refractory Metastatic Breast Cancer

HALAVEN (eribulin mesylate) for Refractory Metastatic Breast Cancer

This slideshow reviews drug information for HALAVEN (eribulin mesylate), indicated for refractory metastatic breast cancer.
Table of Contents
Slide 3: Indication, Dosage, ...

XELODA®

XELODA®

This slideshow reviews drug information for XELODA® (capecitabine) for treatment of metastatic breast cancer.

Table of Contents

Slide 3: Indication, Dosage, and ...

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs